Xeris Biopharma Holdings Inc (XERS)

Financing Cash Flow

$1.94M

Quarterly · Period ending: · USD

XERS logo

XERS Financing Cash Flow

Latest reported$1.94M
XERS Quarterly Cash from Financing (-$368.00K → $1.94M)
High-resolution chart · PNG

XERS financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
1,943,000
-8,837,000
-266,000
13,850,000
942,000
-3,137,000
398,000
-83,000
659,000
35,194,000
-49,000
-72,000
556,000
-863,000
49,156,000
-187,000
310,000
78,194,000
125,000
1,000
460,000
26,661,000
3,326,000
13,063,000
69,608,000
40,067,000
1,970,000
22,570,000
-157,000
56,147,000
29,000
13,183,000
90,796,000
24,203,000
5,467,000
19,000
30,021,000
-368,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.